High-throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion

Affiliations

• ¹ Department of Medical Oncology, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310002, P. R. China.
• ² Department of Pathology, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, P. R. China.
• ³ Department of Thoracic Oncology, Hunan Cancer Hospital, Changsha, Hunan, 410013, P. R. China.
• ⁴ Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, 314000, P. R. China.
• ⁵ Tumor Molecular Laboratory, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, 314000, P. R. China.
• ⁶ HeliTec Biotechnologies, Shenzhen, Guangdong, 518000, P. R. China.
• ⁷ Betta Pharmaceutical, Hangzhou, Zhejiang, 311100, P. R. China.
• ⁸ Department of Radiotherapy, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310022, P. R. China.